Transplantation & Immunology

Designing Clinical Trials for Innovative RRT Products: A New KHI Project

KHI_Logo-Horizontal-Color_0.jpgThe Advancing American Kidney Health initiative made developing an artificial kidney a national priority. The increased interest, investment, and innovation brought about by this policy highlight the need for new and improved infrastructure to facilitate innovation.

The American Society of Nephrology and the Department of Health and Human Services launch $1.5 million Phase 2 of prize competition to redesign dialysis

Today, the US Department of Health and Human Services (HHS) and the American Society of Nephrology (ASN) launched the second phase of KidneyX: Redesign Dialysis, a prize competition that seeks to transform kidney care. Redesign Dialysis is part of a series of KidneyX prize competitions to catalyze the development of innovative solutions that can prevent, diagnose, and treat kidney diseases.

Air Pollution, Global Warming Contribute to Kidney Disease

WASHINGTON, DC – Air pollution, water pollutants, and global warming are among the environmental factors contributing to the development of kidney disease, according to a presenter at Kidney Week 2019.

Gut Microbiome Altered in Kidney Transplant Recipients

WASHINGTON, DC – Kidney transplant recipients have an imbalance of gut bacteria marked by a lower diversity of organisms and increased levels of Proteobacteriae such as Escherichia coli compared with healthy renal donors, according to new research presented at Kidney Week 2019.

Fourth Annual NephJC Kidneys Awards Announces Winner of New CJASN NephJC Kidney Award for Best Visual Abstract 2019

The fourth annual NephJC Kidneys awards were hosted in Washington, DC on Friday, November 8 to coincide with ASN Kidney Week 2019. NephJC is an online medical journal club. They utilize social media and, in particular, the Twitter community to generate discussion and review current literature related to nephrology. It is open to anyone: nephrologists, residents, fellows, cardiologists, internists, urologists, radiologists, pharmacologists, and patients contribute to the discussion. Many contributors attended the NephJC event and took part in the Tweet-up.

Capturing the Patient’s Perspective at Kidney Week 2019

The third day of the ASN Kidney Week Annual Meeting included a heavy emphasis on the patient perspective of kidney disease. Three concurrent sessions on Saturday afternoon included speakers living with kidney disease. One of those sessions was the Celeste Castillo Lee Memorial Lecture, a unique lecture amongst medical society meetings.

Kidney Health Initiative Aims to Spur Innovation in Kidney Sphere Through Collaboration With FDA, Others

KHI_Logo-Horizontal-Color.jpgThe Kidney Health Initiative (KHI) hosted a stimulating session entitled, “The Time Is Now: Using Partnerships to Spur Innovation” which described some lessons on bringing communities from the perspective of the US Food and Drug Administration and KHI.

The session speakers included:

Caloric Restriction Could Help Obese Patients with Kidney Disease

WASHINGTON – Caloric restriction, whether through diet, bariatric surgery, or new sodium-glucose cotransporter-2 inhibitor (SGLT2) medications, could help improve measures of kidney disease in obese patients, according to a Kidney Week 2019 presentation.

Kidney Week Discussion Panel on Disruption in Kidney Care Focused on Need for a Patient-Centered Process

An exciting, and sometimes heated, panel and audience discussion occurred today at Kidney Week 2019 on the subject of disruptors in the nephrology market. Major new healthcare players are entering kidney care, bringing perspectives and expertise on technology, big data, and artificial intelligence and integrated payer-provider platforms. These innovators are working to transform the landscape in kidney care. The audience was standing room only and the hour-long question period had a line the entire time.

The five panelists included:

Biopsies the “Imperfect Gold Standard” for Diagnosing Post-Transplant Rejection

WASHINGTON, DC -- Biopsies remain the gold standard for diagnosing post-transplant kidney disease but they are imperfect, a speaker said here during Kidney Week 2019. Emerging biomarkers may provide a complement to helping nephrologists diagnose and manage disease. The session entitled, "Needle Phobia: Kidney Transplant Biopsy Alternatives", included four speakers on the topic.

Pages